Thermo Fisher Scientific Inc. ranks second on the list of 10 Best Investments During A Recession. Stifel analyst Daniel Arias raised the price target to $700 from $583, citing a “solid year” ahead with mid-single digit organic growth and strong EPS growth driven by the biopharma industry’s expected rebound.

Thermo Fisher Scientific Inc. (TMO) and NVIDIA partner to integrate advanced AI into lab workflows. The collaboration aims to enhance pharmaceutical discovery, research accuracy, and operational efficiency by utilizing NVIDIA’s AI infrastructure and TMO’s life science expertise to modernize experiment planning and data processing.

TMO is a global leader in life sciences tools, laboratory equipment, and analytical instruments, serving biopharma, healthcare, and academic markets. While TMO shows investment potential, other AI stocks may offer greater upside with less risk. A free report on the best short-term AI stock is available for those interested in exploring investment opportunities in the AI sector.

Read more at Yahoo Finance: Thermo Fisher Scientific Inc. (TMO) and NVIDIA Partner to Bring Advanced AI to Lab Workflows